<DOC>
<DOCNO>EP-0651763</DOCNO> 
<TEXT>
<INVENTION-TITLE>
OLIGOPEPTIDE COLLAGEN DERIVATIVES AND THEIR USE IN SECONDARY CATARACT PREVENTION.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61F200	A61F200	A61K3800	A61K3800	A61L2700	A61L2724	A61P2700	A61P2702	A61P2712	C07K500	C07K509	C07K14435	C07K1478	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61F	A61F	A61K	A61K	A61L	A61L	A61P	A61P	A61P	C07K	C07K	C07K	C07K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61F2	A61F2	A61K38	A61K38	A61L27	A61L27	A61P27	A61P27	A61P27	C07K5	C07K5	C07K14	C07K14	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention discloses particularly compounds of formula (I) in which : X1 is a hydrogen atom, a Gly residu or an N-protective group, and X2 is a hydroxy group, a Ser residu, a Ser-Pro or Ser-Pro-Cys group or a group of formula (II), in which R1 and R2 are independently a C1-C18 alkyl group, a C3-C8 cycloalkyl group, an aryl(C1-C4)alkyl group, and R1 may be H, or R1 et R2 together and with the nitrogen atom to which they are fixed form a pyrrolidino, piperidino or piperazinyl group optionally substituted by a C1-C4 alkyl radical or a 4-hydroxypiperidino group, or one of its addition salts with a pharmaceutical acceptable acid, used for the preparation of a secondary cataract prevention drug.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
CHAUVIN LAB SA
</APPLICANT-NAME>
<APPLICANT-NAME>
LABORATOIRE CHAUVIN SA
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BONNE CLAUDE
</INVENTOR-NAME>
<INVENTOR-NAME>
CHAMBON ODILE
</INVENTOR-NAME>
<INVENTOR-NAME>
REGNOUF DE VAINS JEAN-BERNARD
</INVENTOR-NAME>
<INVENTOR-NAME>
BONNE, CLAUDE
</INVENTOR-NAME>
<INVENTOR-NAME>
CHAMBON, ODILE
</INVENTOR-NAME>
<INVENTOR-NAME>
REGNOUF DE VAINS, JEAN-BERNARD
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
